- Home
- WSO vs ILMN Comparison
WSO vs ILMN Comparison
Compare WSO & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSO
- ILMN
- Stock Information
- Founded
- WSO 1945
- ILMN 1998
- Country
- WSO United States
- ILMN United States
- Employees
- WSO N/A
- ILMN N/A
- Industry
- WSO Industrial Machinery/Components
- ILMN Medical Specialities
- Sector
- WSO Consumer Discretionary
- ILMN Health Care
- Exchange
- WSO Nasdaq
- ILMN Nasdaq
- Market Cap
- WSO 18.6B
- ILMN 15.3B
- IPO Year
- WSO N/A
- ILMN 2000
- Fundamental
- Price
- WSO $346.78
- ILMN $120.19
- Analyst Decision
- WSO Hold
- ILMN Hold
- Analyst Count
- WSO 8
- ILMN 15
- Target Price
- WSO $435.00
- ILMN $114.93
- AVG Volume (30 Days)
- WSO 490.6K
- ILMN 1.9M
- Earning Date
- WSO 10-29-2025
- ILMN 10-30-2025
- Dividend Yield
- WSO 3.48%
- ILMN N/A
- EPS Growth
- WSO N/A
- ILMN N/A
- EPS
- WSO 12.87
- ILMN 4.46
- Revenue
- WSO $7,414,495,000.00
- ILMN $4,288,000,000.00
- Revenue This Year
- WSO N/A
- ILMN N/A
- Revenue Next Year
- WSO $5.08
- ILMN $2.22
- P/E Ratio
- WSO $26.79
- ILMN $26.93
- Revenue Growth
- WSO N/A
- ILMN N/A
- 52 Week Low
- WSO $344.52
- ILMN $68.70
- 52 Week High
- WSO $571.42
- ILMN $153.06
- Technical
- Relative Strength Index (RSI)
- WSO 36.71
- ILMN 63.59
- Support Level
- WSO $344.52
- ILMN $118.50
- Resistance Level
- WSO $355.57
- ILMN $125.50
- Average True Range (ATR)
- WSO 9.61
- ILMN 5.19
- MACD
- WSO -0.02
- ILMN 1.13
- Stochastic Oscillator
- WSO 4.90
- ILMN 81.50
About WSO Watsco Inc.
Watsco is the largest heating, ventilation, air conditioning, and refrigeration products distributor in North America. The company primarily operates in the United States (90% of revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada (5% of sales) and Latin America (5% of sales). The company's customer base consists of more than 125,000 contractors that serve the replacement and new construction HVACR markets for residential and light commercial applications.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.